Health care startups in DACH
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Laza Medical | Pfaffikon | Series B | $160.0M | 2026-11-04 |
| Tubulis | Munich | Series C | $400.6M | 2025-10-15 |
| Rivia | Zürich | Series A | $15.0M | 2026-03-18 |
| Exciva | Heidelberg | Series B | $59.4M | 2026-01-20 |
| Vaderis Therapeutics | Basel | Series B | $152.0M | 2026-08-11 |
| Seamless Therapeutics | Dresden | Seed | $12.6M | 2024-04-23 |
| NVision Quantum Technologies | Ulm | Series B | $38.0M | 2026-05-13 |
| DISCO Pharmaceuticals | Cologne | Seed | $42.3M | 2025-12-11 |
8 rows of the CSV in 5 of its 18 columns.
- The 1,102 health care startups in DACH have raised $11.2B in total.
- 110 of them closed their most recent round in the last 12 months, $1.7B combined.
- The largest of those rounds is Oviva's $233.7M Series D, dated January 2026.
- The most recent is SRTD Biotech's $35.2M seed round on 9 November 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 72 of them, more than any other fund.
- Biotech is the most common other sector, with 384 companies (35%).
- 37% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (47% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 1,102| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon, Switzerland | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| Avea Life | Avea Life formulates science-based longevity supplements in Switzerland. | Health care | Zug, Switzerland | Angel | $2.2M | 2026-10-20 | $7.6M | Maximon | 1 to 10 | 2021 |
| Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne, Germany | Series A | $1.7M | 2026-10-20 | $15.3M | European Innovation Council, Fraunhofer Venture, CK Venture Capital | 11 to 50 | 2017 |
| Allogenetics | Allogenetics addresses organ rejection following transplantation. | Health care | Hanover, Germany | Seed | $4.4M | 2026-09-09 | $8.2M | NBank Capital, Carma Fund | 1 to 10 | 2022 |
| NovaGo Therapeutics | NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. | Biotech | Schlieren, Switzerland | Series B | $29.7M | 2026-08-31 | $39.7M | Kinled Holding, Pureos Bioventures | 1 to 10 | 2015 |
| Bewelab SA | Bewelab SA uses neuroscience-based digital interventions to reduce cravings at the neural level. | Health care | Fribourg, Switzerland | Seed | $2.5M | 2026-08-19 | $5.5M | Future of Health Grant, Fribourg Innovation | 1 to 10 | 2021 |
| Vaderis Therapeutics | Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. | Biotech | Basel, Switzerland | Series B | $152.0M | 2026-08-11 | $170.6M | Medicxi | 11 to 50 | 2019 |
| Carewell | Carewell connects caregivers with flexible work opportunities through a marketplace platform. | Health care | Pully, Switzerland | Seed | $1.9M | 2026-07-03 | $2.4M | Foundation for Innovation and Technology (FIT) | 1 to 10 | 2024 |
| Graph Therapeutics | Graph Therapeutics uses AI and multi-omics analysis of patient cells to develop precision immunology treatments. | Artificial intelligence | Klosterneuburg, Austria | Seed | $5.0M | 2026-06-22 | $9.4M | SquareOne Venture Capital, Merantix Capital | 1 to 10 | 2024 |
| SOMAREALITY | SOMAREALITY develops spatial computing and eye tracking technology to measure cognitive digital biomarkers. | Education | Vienna, Austria | Series A | $3.4M | 2026-06-18 | $8.4M | Startup Wise Guys, The Austrian Research Promotion Agency (FFG), Gateway Ventures +2 | 11 to 50 | 2019 |
| Xena | Xena uses artificial intelligence to assist gynecological surgeons during precision surgical procedures. | Artificial intelligence | Mannheim, Germany | Pre-seed | $327K | 2026-05-29 | $545K | Techstars | 1 to 10 | 2023 |
| NVision Quantum Technologies | NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. | Biotech | Ulm, Germany | Series B | $38.0M | 2026-05-13 | $155.2M | Entrée Capital, European Commission, Playground Global +2 | 101 to 250 | 2015 |
| Windward Bio | Windward Bio develops monoclonal antibodies for advanced immunological diseases. | Biotech | Basel, Switzerland | Series B | $165.0M | 2026-05-04 | $365.0M | Qiming Venture Partners, OrbiMed, Novo Holdings +2 | 11 to 50 | 2024 |
| Tacalyx | Tacalyx develops cancer therapies that target tumor-associated carbohydrate antigens. | Biotech | Berlin, Germany | Seed | $12.9M | 2026-04-29 | $28.0M | HTGF (High-Tech Gruenderfonds), coparion, Kurma Partners +2 | 1 to 10 | 2019 |
| mbiomics | mbiomics is a biotechnology company. | Biotech | Munich, Germany | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| dehaze | Dehaze brings medical AI models into clinical practice to provide healthcare services. | Artificial intelligence | Munich, Germany | Seed | $3.7M | 2026-04-28 | $3.8M | Techstars | 1 to 10 | 2023 |
| Cellbricks Therapeutics | Cellbricks Therapeutics is a biotech company developing methods for replacing tissue and organs. | Biotech | Berlin, Germany | Seed | $8.1M | 2026-03-25 | $11.6M | b.value AG, Brooks Hill Partners | 11 to 50 | 2016 |
| Rivia | Rivia provides an operating system that aims to improve clinical trial outcomes. | Artificial intelligence | Zürich, Switzerland | Series A | $15.0M | 2026-03-18 | $18.2M | Speedinvest, Nina Capital, Amino Collective | 1 to 10 | 2022 |
| Alithea Genomics | Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. | Biotech | Lausanne, Switzerland | Seed | $3.8M | 2026-03-04 | $9.9M | Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 | 11 to 50 | 2020 |
| RAYDIAX | RAYDIAX manufactures therapy-assist CT systems that enable minimally invasive interventions. | Hardware | Magdeburg, Germany | Series A | $5.9M | 2026-03-01 | $12.5M | HTGF (High-Tech Gruenderfonds), bmp Ventures, Federal Ministry for Economic Cooperation and Development | 11 to 50 | 2022 |
| nyra health | Nyra Health offers an AI and evidence-based neurological research tablet app for therapy. | Artificial intelligence | Vienna, Austria | Series A | $23.6M | 2026-02-24 | $28.5M | Wellington Partners, MassMutual Ventures, Hardlymountain | 11 to 50 | 2020 |
| Custom Surgical | Custom Surgical builds AI-powered imaging data management and digitization tools for eyecare. | Health care | Munich, Germany | Seed | $4.1M | 2026-02-19 | $4.7M | Luminate | 11 to 50 | 2019 |
| ORamaVR | ORamaVR develops extended reality software that speeds up computational medical applications. | Education | Geneva, Switzerland | Seed | $4.5M | 2026-01-27 | $5.9M | European Commission, Innosuisse, FONGIT +1 | 11 to 50 | 2016 |
| Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne, Switzerland | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| Altavo | Altavo develops medical devices as a startup. | Health care | Dresden, Germany | Series A | $3.5M | 2026-01-22 | $8.9M | HTGF (High-Tech Gruenderfonds), TGFS - Technologiegründerfonds Sachsen, bm-t beteiligungsmanagement thuringen +2 | 11 to 50 | 2021 |
| Exciva | Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. | Biotech | Heidelberg, Germany | Series B | $59.4M | 2026-01-20 | $69.8M | Andera Partners, LBBW VC, Cure8 Ventures | 1 to 10 | 2015 |
| FluoSphera | FluoSphera develops drugs. | Biotech | Geneva, Switzerland | Seed | $1.4M | 2026-01-12 | $3.9M | SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 | 1 to 10 | 2021 |
| Genknowme | Genknowme is a precision health company advancing epigenetics to support personalized and preventive care. | Biotech | Lausanne, Switzerland | Pre-seed | $630K | 2025-12-18 | $947K | Venture Kick, Foundation for Innovation and Technology (FIT) | 1 to 10 | 2019 |
| DISCO Pharmaceuticals | DISCO Pharmaceuticals performs large-scale surfaceome mapping of cancer cells to find drug targets. | Health care | Cologne, Germany | Seed | $42.3M | 2025-12-11 | $64.0M | Sofinnova Partners, M Ventures, AbbVie +1 | 11 to 50 | 2022 |
| Mirantus Health | Mirantus Health is building a distributed healthcare provider to improve access to care for underserved patients. | Health care | Berlin, Germany | Seed | $6.3M | 2025-11-20 | $6.3M | Revent, Springboard Health Angels | 11 to 50 | 2022 |
Table 1. Health care startups in DACH: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,102.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Windward Bio | Windward Bio develops monoclonal antibodies for advanced immunological diseases. | Biotech | Basel, Switzerland | Series B | $165.0M | 2026-05-04 | $365.0M | Qiming Venture Partners, OrbiMed, Novo Holdings +2 | 11 to 50 | 2024 |
| 2 | Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon, Switzerland | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| 3 | Vaderis Therapeutics | Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. | Biotech | Basel, Switzerland | Series B | $152.0M | 2026-08-11 | $170.6M | Medicxi | 11 to 50 | 2019 |
| 4 | Exciva | Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. | Biotech | Heidelberg, Germany | Series B | $59.4M | 2026-01-20 | $69.8M | Andera Partners, LBBW VC, Cure8 Ventures | 1 to 10 | 2015 |
| 5 | DISCO Pharmaceuticals | DISCO Pharmaceuticals performs large-scale surfaceome mapping of cancer cells to find drug targets. | Health care | Cologne, Germany | Seed | $42.3M | 2025-12-11 | $64.0M | Sofinnova Partners, M Ventures, AbbVie +1 | 11 to 50 | 2022 |
| 6 | NVision Quantum Technologies | NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. | Biotech | Ulm, Germany | Series B | $38.0M | 2026-05-13 | $155.2M | Entrée Capital, European Commission, Playground Global +2 | 101 to 250 | 2015 |
| 7 | NovaGo Therapeutics | NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. | Biotech | Schlieren, Switzerland | Series B | $29.7M | 2026-08-31 | $39.7M | Kinled Holding, Pureos Bioventures | 1 to 10 | 2015 |
| 8 | Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne, Switzerland | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| 9 | nyra health | Nyra Health offers an AI and evidence-based neurological research tablet app for therapy. | Artificial intelligence | Vienna, Austria | Series A | $23.6M | 2026-02-24 | $28.5M | Wellington Partners, MassMutual Ventures, Hardlymountain | 11 to 50 | 2020 |
| 10 | Rivia | Rivia provides an operating system that aims to improve clinical trial outcomes. | Artificial intelligence | Zürich, Switzerland | Series A | $15.0M | 2026-03-18 | $18.2M | Speedinvest, Nina Capital, Amino Collective | 1 to 10 | 2022 |
Table 2. Health care startups in DACH: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 72 | 7% | 5 | CereGate, Tacalyx, mbiomics |
| 2 | Venture Kick | Startup incubator | Schlieren, Switzerland | 51 | 5% | 1 | Genknowme |
| 3 | Bayern Kapital | Venture capital firm | Landshut, Germany | 19 | 2% | 1 | mbiomics |
| 4 | KfW | Government investment office | Frankfurt, Germany | 19 | 2% | ||
| 5 | Innosuisse | Government investment office | Berne, Switzerland | 17 | 2% | 1 | ORamaVR |
| 6 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | 13 | 1% | 3 | Carewell, Alithea Genomics, Genknowme |
| 7 | Verve Ventures | Venture capital firm | Zug, Switzerland | 12 | 1% | ||
| 8 | IBB Ventures | Venture capital firm | Berlin, Germany | 12 | 1% | 1 | Ascléa |
| 9 | Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | 10 | 1% | ||
| 10 | BioMedPartners | Venture capital firm | Basel, Switzerland | 10 | 1% | ||
| 11 | MassChallenge | Startup accelerator | Boston, United States | 10 | 1% | ||
| 12 | Andera Partners | Private equity firm | Paris, France | 9 | 1% | 1 | Exciva |
| 13 | Wellington Partners | Venture capital firm | Munich, Germany | 9 | 1% | 1 | nyra health |
| 14 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | 8 | 1% | ||
| 15 | Sofinnova Partners | Venture capital firm | Paris, France | 7 | 1% | 1 | DISCO Pharmaceuticals |
Table 3. Health care startups in DACH: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 384 | 35% | $6.3B |
| Software | 307 | 28% | $1.4B |
| Artificial intelligence | 123 | 11% | $924.5M |
| Hardware | 63 | 6% | $184.1M |
| Commerce | 45 | 4% | $145.9M |
| Fintech | 30 | 3% | $274.9M |
| Education | 22 | 2% | $44.0M |
| Energy | 5 | 0% | $35.1M |
| Cybersecurity | 3 | 0% | $4.7M |
Table 4. Health care startups in DACH by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in DACH by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| Germany | 659 | 60% |
| Switzerland | 353 | 32% |
| Austria | 89 | 8% |
| Liechtenstein | 1 | 0% |
Table 6. Health care startups in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Health care startups in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 4 | 4% | $195.3M |
| October 2026 | 9 | 8% | $144.1M |
| September 2026 | 10 | 9% | $64.6M |
| August 2026 | 7 | 6% | $193.3M |
| July 2026 | 7 | 6% | $45.7M |
| June 2026 | 12 | 11% | $176.6M |
| May 2026 | 10 | 9% | $256.8M |
| April 2026 | 8 | 7% | $56.0M |
| March 2026 | 10 | 9% | $54.2M |
| February 2026 | 11 | 10% | $89.0M |
| January 2026 | 12 | 11% | $337.7M |
| December 2025 | 7 | 6% | $76.0M |
| November 2025 | 3 | 3% | $9.3M |
Table 8. Health care startups in DACH: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 100 | 9% | $1.6B |
| 2025 | 111 | 10% | $1.3B |
| 2024 | 137 | 12% | $1.9B |
| 2023 | 117 | 11% | $533.8M |
| 2022 | 144 | 13% | $759.8M |
| 2021 | 100 | 9% | $768.2M |
Table 9. Health care startups in DACH by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 111 | 10% |
| 2020 to 2022 | 296 | 27% |
| 2015 to 2019 | 388 | 36% |
| 2010 to 2014 | 170 | 16% |
| Before 2010 | 123 | 11% |
Table 10. Health care startups in DACH by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 508 | 47% |
| 11 to 50 | 448 | 41% |
| 51 to 100 | 77 | 7% |
| 101 to 250 | 32 | 3% |
| 251 to 500 | 13 | 1% |
| 501 to 1,000 | 4 | 0% |
| 1,001 to 5,000 | 4 | 0% |
| 10,001 or more | 2 | 0% |
Table 11. Health care startups in DACH by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in DACH. On 16 November 2026 that is 1,102 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 1,102 rows: 371 have no round amount, 0 no city and 417 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in DACH are on the list?
- 1,102, in the file dated 16 November 2026. 110 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 1,102 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.